Fact CheckerSign in

NCT07290309Recruiting

Survivors Uniting for Remote Guided Exercise

Efficacy of a Group-based Videoconference Intervention to Increase Physical Activity in Cancer Survivors

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

The goal of this research study is to look at how live, online group exercise compares to recorded videos for helping increase physical activity levels, improve physical fitness and quality of life, and reduce loneliness among those living with and beyond cancer. The following aims have been established for this study: * Aim 1: Examine the effect of a group-based videoconference physical activity (PA) intervention on moderate to vigorous physical activity \[MVPA\] (i.e., aerobic and resistance exercise). * Aim 2: Examine the effect of the intervention on additional health-related outcomes including physical fitness (i.e., aerobic endurance, muscular strength), and quality of life at both timepoints. * Aim 3: Explore potential mediators and moderators of intervention effects. We will examine mediators (e.g., self-efficacy, outcome expectations, group cohesion) and moderators (e.g., age, cancer stage, neighborhood walkability) of the intervention on MVPA. * Exploratory Aim: Determine whether a group-based videoconference PA intervention reduces loneliness among cancer survivors. Researchers will randomize participants into one of two guided exercise groups that are 12-weeks long in duration. Participants will be asked to complete online fitness assessments and surveys as well as wear a physical activity monitor device and watch a few times throughout the study. The whole study is 9-months long in duration with a 6-month free-living period where no study activities will take place.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
15 Dec 2025
Start date
6 Feb 2026
Primary completion date
1 Dec 2029
Lead sponsor
Colorado State University
NCT number
NCT07290309

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 6 Feb 2026 to the primary completion date, 1 Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device)

Other

  • Existing participation in ≥150 minutes per week of at least moderate intensity aerobic exercise
  • Current or planned participation in another structured program or intervention intended to encourage participation in exercise or physical activity.

Who the study is looking for

  • Able to speak/read English,
  • Diagnosed with any type of cancer within the last 5 years
  • Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy, immunotherapies)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Human Performance Clinical Research Lab
Coordinator of this site? Confirm its status
Fort CollinsUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.